Front & Back Matter.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 5/6, p. 1, doi. 10.1159/000521278
- Publication type:
- Article
Works matching IS 00093157 AND DT 2021 AND VI 66 AND IP 5/6
Results: 9
1
2
Contents, Vol. 66, 2021.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 5/6, p. I, doi. 10.1159/000520921
- Publication type:
- Article
3
Acknowledgement to Reviewers.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 5/6, p. 210, doi. 10.1159/000520920
- Publication type:
- Article
4
The Pentose Phosphate Pathway in Cancer: Regulation and Therapeutic Opportunities.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 5/6, p. 179, doi. 10.1159/000519784
- By:
- Publication type:
- Article
5
Isatuximab plus Pomalidomide and Dexamethasone in a Patient with Dialysis-Dependent Multiple Myeloma.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 5/6, p. 192, doi. 10.1159/000519783
- By:
- Publication type:
- Article
6
The Synergistic Inhibitory Effect of Combining MK-2206 and AZD 6244 in MARIMO Cells Harboring a Calreticulin Gene Mutation.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 5/6, p. 169, doi. 10.1159/000518921
- By:
- Publication type:
- Article
7
Metastatic Renal Cell Carcinoma Classified as Good Risk: The Easiest Choice Has Become the Hardest.
- Published in:
- 2021
- By:
- Publication type:
- Letter
8
Detection of NDM-1 and VIM Genes in Carbapenem-Resistant Klebsiella pneumoniae Isolates from a Tertiary Health-Care Center in Kathmandu, Nepal.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 5/6, p. 199, doi. 10.1159/000518256
- By:
- Publication type:
- Article
9
S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy Regimens.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 5/6, p. 161, doi. 10.1159/000517376
- By:
- Publication type:
- Article